Integrity Applications (OTC: IGAP) is a medical device company focused on the design, development and commercialization of non-invasive glucose monitoring devices for use by people with diabetes. Integrity Applications operates primarily through its wholly owned Israeli subsidiary, A.D. Integrity Applications, Ltd. The company has developed the GlucoTrack® model DF-F, a technology intended for use in non-invasive quantitative spot measurement of glucose, for home-use. The GlucoTrack model DF-F has been proven for safety and performances for patients in clinical studies conducted by third party, under the supervision of leading diabetes authorities at the Soroka University Medical Center in Israel. The upgraded device gained a CE-Mark approval in December 2015. For more information, visit the company’s website at www.integrity-app.com